Tampa, FL – According to filings with the U.S. Securities and Exchange Commission, ProtoLytic is raising $3,679,257.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Thomas Sweet played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About ProtoLytic

Our vision is to be the premier provider of evidence-based decision support systems for insurance companies, employers and third-party administrators to evaluate, process and fulfill medical service requests quickly and consistently in order to optimize treatment results, improve patient well-being and increase patient satisfaction with care.

To learn more about ProtoLytic, visit http://www.protolytic.com/

Contact:
Thomas Sweet, Chief Executive Officer
813-625-7227
tsweet@protolytic.com
https://www.linkedin.com/in/tom-sweet-03b16114b/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved